Skip to main content

MoneyWorks4Me

Divis Laboratories informs about quarterly statement of investor complaints

11 Apr 2016 Evaluate

Divis Laboratories has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended March 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1746.30
Dr. Reddys Labs. 1362.30
Cipla 1382.15
Lupin 2016.45
Zydus Lifesciences 1239.05
View more..